Lymphoproliferative disorders after allogeneic T- and B-cell depleted haematopoietic cell stem transplantation

被引：0
|
作者：
Liga, M. [1 ]
Carotti, A. [1 ]
Aloisi, T. [1 ]
Incarnato, F. [2 ]
Castronari, R. [2 ]
Sensini, A. [2 ]
D'Arro', B. [1 ]
Decarolis, L. [1 ]
Felicini, R. [1 ]
Gurdo, G. [1 ]
Martelli, M. F. [1 ]
Gambacorta, M. [3 ]
Falini, B. [1 ]
Aversa, F. [1 ]
机构：
[1] Sect Hematol, HSCT Unit, Perugia, Italy
[2] Dept Expt & Biochem Med, Microbiol Sect, Perugia, Italy
[3] Osped Niguarda Ca Granda, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [31] High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment
    Juvonen, E
    Aalto, SM
    Tarkkanen, J
    Volin, L
    Mattila, PS
    Knuutila, S
    Ruutu, T
    Hedman, K
    BONE MARROW TRANSPLANTATION, 2003, 32 (01) : 97 - 102
  • [32] ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL
    Schlegel, Patrick
    Jung, Gundram
    Lang, Anne-Marie
    Doering, Michaela
    Schulte, Johannes H.
    Ebinger, Martin
    Holzer, Ursula
    Heubach, Florian
    Seitz, Christian
    Lang, Barbara
    Hundsdoerfer, Patrick
    Eggert, Angelika
    Eichholz, Thomas
    Kreyenberg, Hermann
    Lang, Peter
    Handgretinger, Rupert
    BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) : 689 - 693
  • [33] High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment
    E Juvonen
    S M Aalto
    J Tarkkanen
    L Volin
    P S Mattila
    S Knuutila
    T Ruutu
    K Hedman
    Bone Marrow Transplantation, 2003, 32 : 97 - 102
  • [34] ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL
    Patrick Schlegel
    Gundram Jung
    Anne-Marie Lang
    Michaela Döring
    Johannes H. Schulte
    Martin Ebinger
    Ursula Holzer
    Florian Heubach
    Christian Seitz
    Barbara Lang
    Patrick Hundsdörfer
    Angelika Eggert
    Thomas Eichholz
    Hermann Kreyenberg
    Peter Lang
    Rupert Handgretinger
    Bone Marrow Transplantation, 2019, 54 : 689 - 693
  • [35] Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation
    Francesco Pegoraro
    Claudio Favre
    Annals of Hematology, 2021, 100 : 865 - 878
  • [36] Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation
    Pegoraro, Francesco
    Favre, Claudio
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 865 - 878
  • [37] Transfusion requirements after allogeneic haematopoietic stem cell transplantation
    Bini-Antunes, M
    Santos, L
    Campilho, F
    Rosales, M
    Amado, F
    Campos, A
    Vaz, CP
    Pimentel, P
    Carvalhais, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S121 - S122
  • [38] Post-transplant lymphoproliferative disease (PTLD): high incidence after non-T-cell-depleted allogeneic stem cell transplantation
    Juvonen, E
    Aalto, S
    Volin, L
    Ruutu, T
    Tarkkanen, J
    Piiparinen, H
    Hedman, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S27 - S28
  • [39] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Yok-Lam Kwong
    Annals of Hematology, 2016, 95 : 1191 - 1192
  • [40] Cerebral infections after allogeneic haematopoietic stem cell transplantation
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Keller, MT
    Schulte, C
    Hlinka, M
    Koldehoff, M
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2006, 37 : S168 - S168
12345